Uncategorized

BOSTON — After a full day of oral arguments in a packed courtroom, Boston federal judge Brian E. Murphy did not rule from the bench on a lawsuit from the American Academy of Pediatrics, the professional body representing the country’s pediatricians, against the Department of Health and Human Services, focused on vaccines.   The judge asked […]

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Sanofi is replacing Paul Hudson as CEO, the company announced Thursday, spurning his attempts to bolster the company’s pipeline amid recent clinical setbacks.  The company’s board has tapped Belén Garijo, the CEO of Merck KGgA, to […]

The Oregon Health and Science University board of directors unanimously passed a resolution authorizing negotiations with the National Institutes of Health that could end all experiments on monkeys and shift the federally funded Oregon National Primate Research Center into a sanctuary. The vote came as the NIH looks to transition at least one of seven […]

Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk’s obesity pill on its telehealth platform, after health officials called for an investigation of the company for potentially violating federal law. Hims launched the compounded drug earlier this week at $49 month. That prompted […]

Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package inserts and discussed in exam rooms over the years, pose barriers to many patients, doctors say.  A new meta-analysis hopes to set the […]

WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff and external concerns about a controversial new program to fast-track certain drugs.   “This pilot is an effort to make our review processes patient-centric,” said Mallika Mundkur, deputy chief medical officer and leader of the new drug review […]

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Sanofi’s Cerezyme has long been used as a treatment for Gaucher disease, a rare illness that can cause enlarged spleens and livers, bone pain, and fatigue. Patients with the kind of Gaucher that causes neurological problems, […]

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which […]

The Department of Health and Human Services on Wednesday announced the appointment of 21 new members to a federal committee that advises health secretary Robert F. Kennedy Jr. on autism. Many of the new members of the Interagency Autism Coordinating Committee share a common trait: They have publicly expressed or belong to groups that have […]

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. The Trump administration plans to increase payments to […]